[go: up one dir, main page]

ES2049678A6 - Novel cyclobutane derivative and process for producing same - Google Patents

Novel cyclobutane derivative and process for producing same

Info

Publication number
ES2049678A6
ES2049678A6 ES9050027A ES9050027A ES2049678A6 ES 2049678 A6 ES2049678 A6 ES 2049678A6 ES 9050027 A ES9050027 A ES 9050027A ES 9050027 A ES9050027 A ES 9050027A ES 2049678 A6 ES2049678 A6 ES 2049678A6
Authority
ES
Spain
Prior art keywords
producing same
cyclobutane derivative
novel
novel cyclobutane
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES9050027A
Other languages
Spanish (es)
Inventor
Yuh-Ichiro Ichikawa
Aya Narita
Kaoru Matsuo
Keiko Aoyama
Fumiko Matsumura
Yukihiro Nishiyama
Kenichi Matsubara
Takemitsu Nagahata
Hiroo Hoshino
Jun-Ichi Seki
Koichi Narasaka
Yujiro Hayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Kayaku Co Ltd
Original Assignee
Nippon Kayaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Co Ltd filed Critical Nippon Kayaku Co Ltd
Publication of ES2049678A6 publication Critical patent/ES2049678A6/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

This invention relates to cyclobutane derivatives represented by general formula (IV), wherein B represents a nucleic acid base and R4 represents hydrogen atom or a protecting group, which is expectedly useful as an antiviral agent or a carcinostatic agent.
ES9050027A 1988-11-22 1989-11-22 Novel cyclobutane derivative and process for producing same Expired - Lifetime ES2049678A6 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP29513588 1988-11-22
JP4303689 1989-02-27
JP15822389 1989-06-22

Publications (1)

Publication Number Publication Date
ES2049678A6 true ES2049678A6 (en) 1994-04-16

Family

ID=27291425

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9050027A Expired - Lifetime ES2049678A6 (en) 1988-11-22 1989-11-22 Novel cyclobutane derivative and process for producing same

Country Status (5)

Country Link
ES (1) ES2049678A6 (en)
GB (1) GB2232669B (en)
NL (1) NL8921278A (en)
SE (1) SE501370C2 (en)
WO (1) WO1990005730A2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177348A (en) * 1977-12-13 1979-12-04 United States Government Carbocyclic analogs of cytosine nucleosides
US4617304A (en) * 1984-04-10 1986-10-14 Merck & Co., Inc. Purine derivatives
EP0184473A1 (en) * 1984-10-26 1986-06-11 Merck & Co. Inc. Regioselective synthesis of 9-substituted purine acyclonucleoside derivatives
US4782062A (en) * 1987-05-11 1988-11-01 Merck & Co., Inc. 9-(2-hydroxymethyl)cycloalkylmethyl) guanines
AU622926B2 (en) * 1988-09-09 1992-04-30 Nippon Kayaku Kabushiki Kaisha Pyrimidine or purine cyclobutane derivatives

Also Published As

Publication number Publication date
SE9002445D0 (en) 1990-07-16
WO1990005730A2 (en) 1990-05-31
GB2232669A (en) 1990-12-19
NL8921278A (en) 1990-10-01
SE9002445L (en) 1990-07-16
GB2232669B (en) 1992-11-25
SE501370C2 (en) 1995-01-23
GB9015942D0 (en) 1990-09-05
WO1990005730A3 (en) 1990-09-07

Similar Documents

Publication Publication Date Title
EP0358154A3 (en) Novel cyclobutane derivative and process for producing same
MX9606331A (en) Novel compound, process for producing the same, and antitumor agent.
DE68923250D1 (en) Chalcone derivatives and process for their preparation.
MY104626A (en) A 1-phenylimidazole derivative and its production and use.
EP0394496A4 (en) Glycoside derivatives, polymers containing glycoside derivatives, process for their preparation, and use of said polymers
ES8503343A1 (en) Piperazine substituted carboxamide derivatives, compositions and method of use
CA2035038A1 (en) Synthetic intermediates of 2-alkynyladenosines, processes for preparing the synthetic intermediates, processes for preparing 2-alkynyladenosines utilizing the synthetic intermediates, and stable 2-alkynyladenosine derivatives
HUT48583A (en) Process for production of derivatives of substituated indolinon
EP0714900A3 (en) Alkylhydrohalosilanes, process for their preparation and use
MY101142A (en) 1, 4-dihydropyridine derivative, process for production thereof, and pharmaceutical use thereof.
MY110450A (en) Imidazolylmethyl-pyridines, their production their use as pharmaceuticals and pharmaceutical compositions containing them
EP0277599A3 (en) Fluorine containing cyclopentane derivatives and processes for their production
ES2049678A6 (en) Novel cyclobutane derivative and process for producing same
ATE148128T1 (en) ANTHRACYCLINGLYCOSIDE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
ATE61577T1 (en) FLUORINATED VITAMIN D3 DERIVATIVES AND PROCESS FOR THEIR PRODUCTION.
ATE102955T1 (en) CYCLIC TETRAPEPTIDE AND PROCESS FOR PRODUCTION THEREOF.
ES449629A1 (en) 2-Benzopyranone derivatives, process for their production, their use as medicaments, more especially as coronary dilators
ES2076175T3 (en) PROCEDURE FOR THE PRODUCTION OF 1 ALPHA, 3 BETA, 24-TRIHIDROXI-DELTA 5-STEROIDS.
PL290987A1 (en) Method of synthesizing new compounds
NZ332245A (en) Substituted benzo-oxazolol carboxylic acid derivatives, process for their production and medicaments containing them
HUT47929A (en) Process for producing 4-piperidine-carboxamide derivatives and pharmaceuticals comprising same
ATE135693T1 (en) HALOGENO-4-METHYLPYRAZOLES AND METHOD FOR THE PRODUCTION THEREOF
DK480389D0 (en) ANTITUM SUBSTANCE, PROCEDURE FOR ITS MANUFACTURING AND ANTICANCER CONTAINING THE SUBSTANCE
CA2008751A1 (en) Organogermanium compounds, processes for producing the same and agent for inhibiting the activity of opioid peptide-degrading enzyme
UA41309C2 (en) Derivatives of 11-<font face="Symbol">b</font>-benzaldoximextra-4,9-dien , a process for the preparation thereof and a pharmaceutical composition